Ascent Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.70 M
- Revenue Growth 13.72%
- Profit Growth 114.39%
- Ebitda 74.63%
- Net Worth 41.63%
- Total Assets 8.23%
About Ascent Life Sciences
Ascent Life Sciences Private Limited (ALSPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 October 2010 and has a history of 14 years and three months. Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.70 M.
Gagan Singh and Sinran Bhatia serve as directors at the Company.
Company Details
-
Location
Jaipur, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24232RJ2010PTC033194
-
Company No.
033194
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Oct 2010
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Ascent Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gagan Singh
|
Director | 28-Oct-2010 | Current |
|
Sinran Bhatia
|
Director | 24-Jun-2015 | Current |
Financial Performance of Ascent Life Sciences.
Ascent Life Sciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 13.72% increase. The company also saw a substantial improvement in profitability, with a 114.39% increase in profit. The company's net worth Soared by an impressive increase of 41.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ascent Life Sciences?
In 2020, Ascent Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.70 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.17 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Oct 2021 | Others | ₹1.70 M | Open |
How Many Employees Work at Ascent Life Sciences?
Unlock and access historical data on people associated with Ascent Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ascent Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ascent Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
